Archives
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Hill and colleagues estimate that globally about million CI
2019-06-10

Hill and colleagues\' estimate that, globally, about 1·5 million (95% CI 1·2–1·8) children aged 5–14 years died in 2010. This finding is somewhat higher than the total estimated by the UN of 1·3 million, although the UN estimate is within the investigators\' CI. However, their estimate is 87% higher
-
In vitro test for EEC JAK mutations and
2019-06-10

In vitro test for EEC, JAK2 mutations and paraclinical parameters were performed by routine analysis. Discussion It is always important to make the correct diagnosis – in particular when molecular biological analyses are available. The pursuit of the correct diagnosis was intensified in these po
-
Pharmacological inhibition of PI K induces apoptosis of CLL
2019-06-10

Pharmacological inhibition of PI3Kα induces apoptosis of CLL SAG supplier in vitro [5,18], and inhibits CLL migration towards CXCL12 [5]. The PI3Kα/δ inhibitor copanlisib induces significantly greater apoptosis of CLL cells compared to idelalisib (IC50 of 450nM and >10μM, respectively) in vitro and
-
Many of the emerging non vaccine serotypes in carriage after
2019-06-10

Many of the emerging non-vaccine serotypes in carriage after PCV13 implementation (11A, 15B/C, 15A, 21, 23B, and 35F) show low potential for causing invasive disease, but some—eg, 12F, 22F, 24F, 8, and 9N—have high disease potential. Moreover, in vulnerable populations (eg, immunocompromised people)
-
The Registrar of Pesticides noted
2019-06-10

The Registrar of Pesticides noted this effect of cytokine inhibitors and started banning the most toxic HHPs, initially parathion and methylparathion, in 1984. The exponential rise in total (not just pesticide) suicides then stopped (); the rate began to fall rapidly after 1995, when five further HH
-
Among patients with established infection in the bone or sur
2019-06-10

Among patients with established infection in the bone or surrounding tissue (Stage II) antibiotic penicillin-based therapy in addition to mouthwash may result in healing in patients with minor ONJ lesions. However, a large proportion of cases tend to show chronically infected necrotic process in jaw
-
br Benign bone tumors br Giant
2019-06-10

Benign bone tumors Giant cell tumor of jaws [GCT] GCTs arising in the head and neck region constitute approximately 2% of all GCTs. They are locally aggressive, recurrent and non-metastasing. Neoplastic giant cell are very rare in jaws. GCT usually occurs in children and young adults, predomi
-
The acute effects of goserelin on bone have also been
2019-06-10

The acute effects of goserelin on bone have also been evaluated by prospective trials of goserelin+/− adjuvant tamoxifen. The Zoladex in Premenopausal Patients trial randomized 89 women with early breast cancer to goserelin+/− tamoxifen, tamoxifen alone and no endocrine therapy. After 2 years of tre
-
There is a concern about the possibility that some
2019-06-10

There is a concern about the possibility that some patients with WPW syndrome who have LV dyssynchrony and atypical delta waves, as in the present case, may be diagnosed with DCM. In these WPW syndrome patients, although medical therapy might not improve LV dysfunction, RFCA of the AP might improve
-
Second governments can play an important part
2019-06-06

Second, governments can play an important part in providing incentives for industry to invest in discovering new uses for old drugs. For example, it secreted frizzled related protein could consider the extension of patent protection for old drugs that have found new uses, for example, as embodied i
-
dihydrofolate reductase While immunogenic action of langerha
2019-06-06

While immunogenic action of langerhans dihydrofolate reductase had thoroughly been illustrated, their tolerogenic action is still being in its infancy stage. Ralph. M. Steinman shared the Nobel Prize in 2011 for his work on dendritic cells and their role in immunity. He uncovered the role of dendri
-
br Materials and methods br Results and discussion
2019-06-06

Materials and methods Results and discussion ABT-737 is a BH3-mimetic targeting Bcl-2, Bcl-XL and Bcl-W. The aim of the experiments was to test whether inhibition of Bcl-2 and Bcl-XL using ABT-737 can eradicate the CD34+/CD38− AML cell population. Bone marrow MNCs from patients (Table 1) were
-
Class IC antiarrhythmic drugs such
2019-06-06

Class IC antiarrhythmic drugs such as pilsicainide and propafenone have been used to terminate or prevent ATs, particularly atrial fibrillation [15–17]. Pilsicainide and propafenone in Japan, and ajmaline in Europe, are commonly used as first-line drugs for antiarrhythmic therapy [13]. We often enco
-
The effects of zoledronic acid are most likely due to
2019-06-06

The effects of zoledronic GSK2656157 are most likely due to impairment of the tumour-driven alterations to the bone microenvironment. This may render the bone marrow cavity unfavourable for metastatic growth, potentially redirecting tumour cells to other sites, including the periosteal surface. Whe
-
We present a case report of a patient
2019-06-06

We present a case report of a patient with chronic myeloid leukemia (CML) who developed bilateral renal artery stenosis during tyrosine kinase inhibitor (TKI) therapy. Only a few reports associate TKIs with acute renal failure, and renovascular hypertension has not been previously described. Reports
16583 records 1058/1106 page Previous Next First page 上5页 10561057105810591060 下5页 Last page